Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | PPOX | P50336 | 2/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.34 |
| ▸ | SUV39H2 | Q9H5I1 | 5/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | MALT1 | Q9UDY8 | 3/20 | 0.32 |
| ▸ | JAK3 | P52333 | 1/20 | 0.32 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3632485 | 0.87 | PPOX (0.35) | ALDH1A1LMNASMN1; SMN2PPOXTP53 | |
| SCHEMBL4694944 | 0.85 | CCR1 (0.41) | ALKSUV39H2 | |
| SCHEMBL3635137 | 0.82 | ALK (0.37) | ALDH1A1LMNASMN1; SMN2PPOXTP53 | |
| SCHEMBL3866250 | 0.77 | ALDH1A1 (0.35) | ALDH1A1LMNASMN1; SMN2PPOXTP53 | |
| SCHEMBL1637613 | 0.76 | CCR1 (0.49) | LMNAHSD17B10 | |
| SCHEMBL3639958 | 0.74 | ALDH1A1 (0.35) | ALDH1A1LMNASMN1; SMN2PPOXTP53 | |
| SCHEMBL4016337 | 0.73 | CCR1 (0.37) | ALDH1A1LMNASMN1; SMN2PPOXTP53 | |
| SCHEMBL4019923 | 0.73 | PPOX (0.45) | ALDH1A1LMNASMN1; SMN2PPOXTP53 | |
| SCHEMBL3637368 | 0.72 | CCR1 (0.41) | SUV39H2 | |
| SCHEMBL4013750 | 0.72 | CCR1 (0.41) | ALDH1A1LMNASMN1; SMN2PPOXTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2155203-A1 | AZAINDAZOLE COMPOUNDS AND METHODS OF USE | ChemoCentryx Inc (US) | 2010-02-24 | — | — | EP | disclosed |
| WO-2008147822-A1 | AZAINDAZOLE COMPOUNDS AND METHODS OF USE | CHEMOCENTRYX, INC. (US) | 2008-12-04 | — | — | WO | disclosed |
| EP-1906965-A2 | AZAINDAZOLE COMPOUNDS AND METHODS OF USE | ChemoCentryx Inc (US) | 2008-04-09 | — | — | EP | disclosed |
| WO-2007002293-A2 | AZAINDAZOLE COMPOUNDS AND METHODS OF USE | CHEMOCENTRYX, INC. (US) | 2007-01-04 | — | — | WO | disclosed |